Pilot study on interferon gamma in association with peg-interferon alpha 2a and ribavirin among patients with a chronic hepatitis C and non responders to the association of peg-interferon alpha 2b or 2a and ribavirin ANRS HC16 Gammatri

Trial Profile

Pilot study on interferon gamma in association with peg-interferon alpha 2a and ribavirin among patients with a chronic hepatitis C and non responders to the association of peg-interferon alpha 2b or 2a and ribavirin ANRS HC16 Gammatri

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Aug 2007

At a glance

  • Drugs Interferon gamma; Peginterferon alfa-2a; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 28 Aug 2007 Status changed from terminated to completed.
    • 18 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top